RAAJ MEDISAFE INDIA LTD.

Raaj Medisafe India Ltd has scheduled a Board of Directors meeting for August 12, 2026. The agenda includes appointing a Chief Financial Officer, reviewing unaudited financial results for the quarter ended June 30, 2026, and taking note of various audit reports including secretarial and reconciliation of share capital. The board will also discuss the Directors' Report, Corporate Governance Report, and fix dates for the 41st Annual General Meeting, which will be held via video conferencing. Transactions with related parties for the quarter will also be reviewed.

Raaj Medisafe India Ltd announced that its trading window for Promoters, Directors, Officers, designated employees, and their immediate relatives will be closed from July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain in effect until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending June 30, 2026. The date of the board meeting to approve these results will be communicated separately.

Raaj Medisafe India Limited has announced the audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results in their meeting held on May 29, 2026, following a review by the Audit Committee. The auditors, GDK & Associates, issued an audit report with an unmodified opinion on the financial results.

The Board of Directors of Raaj Medisafe India Ltd approved the audited financial statements and cash flow statement for the year ended March 31, 2026, in its meeting held on May 29, 2026. The board also approved transactions with related parties, authorized RTA for DEMAT conversions, and adopted the Reconciliation of Share Capital Audit for the quarter ended March 31, 2026.

Raaj Medisafe India Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve several key items. These include the approval of financial statements and cash flow statements for the year ended March 31, 2026, reviewing transactions with related parties, and adopting the Reconciliation of Share Capital Audit. The board will also discuss the Integrated (Finance) Report and authorize RTA for physical share dematerialization.

Raaj Medisafe India Limited has approved the allotment of 32,75,000 fully paid-up equity shares having a face value of Rs.10/- each at a price of Rs. 55.00/- per equity share (including premium of Rs. 45/-) to various allottees. This allotment is made on a preferential basis for cash consideration. The company has received in-principle approval from the Stock Exchange i.e., BSE Limited for issue of the aforesaid Equity Shares on a Preferential Basis on 12th March, 2026. The application for listing approval of the stock exchange for the equity shares allotted as above will be made in due course.

Raaj Medisafe India Ltd has announced the closure of the trading window for promoters, their immediate relatives, and designated persons. The closure will be in effect from April 1, 2026, until 48 hours after the declaration of the Audited Financial Results for the quarter ending on March 31, 2026. The date of the Board Meeting for the declaration of the Audited Financial Results has not been announced yet.

Raaj Medisafe India Ltd. has informed BSE that the company's Board of Directors will meet on March 26, 2026, to consider and approve the preferential allotment of 32,75,000 equity shares. The meeting will also discuss the minutes of previous board and committee meetings. The company will file the Corporate Announcement under regulation 29(1) in the XBRL format within the stipulated time and host it on the company's website.

Raaj Medisafe India Ltd. has issued a corrigendum to its unaudited financial results for the quarter ended December 31, 2025. The corrigendum addresses a typographical error in the date of the Board Meeting, which was incorrectly stated as 11th December, 2025 instead of 11th February, 2026 in the original document. The revised financial results and the limited review report are enclosed. The company confirms that there is no other change in the unaudited financial results and the limited review reports for the said period.

Raaj Medisafe India Ltd has reported its financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations stands at INR 2,074.99 lakhs for the quarter and INR 5,521.94 lakhs for the nine-month period. The net profit for the quarter is INR 189.42 lakhs and INR 461.65 lakhs for the nine-month period. The company's earnings per share (EPS) for the quarter is INR 1.44 and INR 3.51 for the nine-month period.